Cite
Impact of the implementation of a Fracture Liaison Service on pharmaceutical expenses for osteoporosis compared to an area without an FLS
MLA
Amparo Molina, et al. “Impact of the Implementation of a Fracture Liaison Service on Pharmaceutical Expenses for Osteoporosis Compared to an Area without an FLS.” Expert Review of Pharmacoeconomics & Outcomes Research, vol. 19, Sept. 2018, pp. 81–87. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....829a1f02315e3c3f64a823692b0296d5&authtype=sso&custid=ns315887.
APA
Amparo Molina, Aida Saavedra, Soledad Ojeda-Bruno, Antonio Naranjo, & Miguel Ángel Negrín. (2018). Impact of the implementation of a Fracture Liaison Service on pharmaceutical expenses for osteoporosis compared to an area without an FLS. Expert Review of Pharmacoeconomics & Outcomes Research, 19, 81–87.
Chicago
Amparo Molina, Aida Saavedra, Soledad Ojeda-Bruno, Antonio Naranjo, and Miguel Ángel Negrín. 2018. “Impact of the Implementation of a Fracture Liaison Service on Pharmaceutical Expenses for Osteoporosis Compared to an Area without an FLS.” Expert Review of Pharmacoeconomics & Outcomes Research 19 (September): 81–87. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....829a1f02315e3c3f64a823692b0296d5&authtype=sso&custid=ns315887.